title: Escalating Loading Dose Regimens of Ticagrelor in Primary Percutaneous Intervention: A Second Opportunity for IIb/IIIa Inhibitors?
authors.forename: Iñigo
authors.initials: I
authors.lastname: Lozano
authors.forename: Juan
authors.initials: J
authors.lastname: Rondan
authors.forename: Jose M
authors.initials: JM
authors.lastname: Vegas
authors.forename: Eduardo
authors.initials: E
authors.lastname: Segovia
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives*; D001792:Blood Platelets / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage* / Q000493:pharmacokinetics*
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000241:Adenosine